GlassScriptPhysician profile
Azieb Lofton
NPI 1144229303
$8,903.04
in general payments reported to CMS, 2019-2025
33 companies · $780 in 2025
The $780 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2020: $129 · 2021: $347 · 2022: $369 · 2023: $367 · 2024: $6,470 · 2025: $780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,615 · Food and Beverage: $1,761 · Travel and Lodging: $1,242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,614.68 |
| Food and Beverage | $1,760.99 |
| Travel and Lodging | $1,241.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,925.38 | 2024-2025 | |
| Abbvie INC. | $472.86 | 2019-2025 | |
| Hologic Sales and Service, LLC | $379.82 | 2019-2025 | Aptima, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Astellas Pharma US INC | $251.66 | 2022-2025 | Veozah |
| Pfizer INC. | $184.11 | 2019-2025 | |
| Avanos Medical | $175.29 | 2019-2024 | On-Q* Pump and Accessories |
| Exeltis, USA INC. | $141.68 | 2019-2024 | Slynd |
| Sumitomo Pharma America, INC. | $113.04 | 2023-2025 | Myfembree |
| Baxter Healthcare | $113.01 | 2025 | Tisseel |
| Gynesonics, INC. | $108.01 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Biogen, INC. | $101.25 | 2025 | Zurzuvae |
| Organon LLC | $97.78 | 2021-2024 | |
| Exact Sciences Corporation | $94.56 | 2023-2024 | Cologuard Collection Kit |
| Shield Therapeutics INC | $88.28 | 2024 | |
| Davol INC. | $86.28 | 2023-2025 | Arista, Arista Ah Flexitip |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $85.92 | 2021-2024 | |
| Boston Scientific Corporation | $50.86 | 2019 | |
| Mylan Pharmaceuticals INC. | $47.38 | 2021-2022 | |
| Sage Therapeutics, LLC | $43.85 | 2024-2025 | Zurzuvae |
| Agile Therapeutics, INC. | $39.71 | 2021 | |
| Avion Pharmaceuticals | $38.58 | 2019-2020 | |
| Alydia Health | $38.16 | 2021 | |
| Mayne Pharma Commercial LLC | $32.60 | 2021-2025 | |
| Allergan, INC. | $26.51 | 2019-2020 | |
| Evofem Biosciences, INC. | $25.92 | 2021-2022 | |
| Covidien LP | $24.01 | 2020 | |
| Organogenesis INC. | $20.13 | 2025 | Cygnus Dual |
| Medtronic, INC. | $19.79 | 2025 | Truclear |
| Millicent US INC | $18.11 | 2025 | Intrarosa, Femlyv |
| Convatec INC. | $15.53 | 2024 | |
| Lupin INC. | $15.18 | 2020 | |
| Therapeuticsmd, INC. | $14.80 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Azieb Lofton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.